Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Tolerability of Subcutaneous TV-46046
NCT03700658Phase 1Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jan 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dmpa-sc in contraception (4 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Number of Participants With Injection Site Reactions at Month 18. Started Jan 2019; status: completed.
02
Drugs
dmpa-sc
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03700658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03700658.